Close
  Indian J Med Microbiol
 

Figure 3: Effect of deguelin on bodyweight and disease activity index score in dextran sulfate sodium-treated colitic mice. All values are depicted as mean ± standard deviation (n = 6). The level of statistical significance was calculated by one-way ANOVA followed by the DMRT test; note: *P < 0.05 when compared with the control group and #P < 0.05 when compared with dextran sulfate sodium-treated group. The deguelin (30 mg/kg) treatment to the dextran sulfate sodium-challenged colitis mice displayed appreciable regain in the body weight and also diminished the disease activity index score, which is close to the normal level when comparing it to the dextran sulfate sodium-induced animals

Figure 3: Effect of deguelin on bodyweight and disease activity index score in dextran sulfate sodium-treated colitic mice. All values are depicted as mean ± standard deviation (<i>n</i> = 6). The level of statistical significance was calculated by one-way ANOVA followed by the DMRT test; note: *<i>P</i> < 0.05 when compared with the control group and <sup>#</sup><i>P</i> < 0.05 when compared with dextran sulfate sodium-treated group. The deguelin (30 mg/kg) treatment to the dextran sulfate sodium-challenged colitis mice displayed appreciable regain in the body weight and also diminished the disease activity index score, which is close to the normal level when comparing it to the dextran sulfate sodium-induced animals